Nianping Zhang

497 total citations
26 papers, 326 citations indexed

About

Nianping Zhang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Nianping Zhang has authored 26 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Nianping Zhang's work include interferon and immune responses (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). Nianping Zhang is often cited by papers focused on interferon and immune responses (2 papers), RNA Interference and Gene Delivery (2 papers) and MicroRNA in disease regulation (2 papers). Nianping Zhang collaborates with scholars based in China, United States and Hong Kong. Nianping Zhang's co-authors include Cun‐Gen Ma, Gajendra Kumar, Han‐Ting Zhang, Yuqing Yan, Lijuan Song, Ye Gao, Dahong Long, Chong Zhang, Jianchun Pan and Jianliang Chen and has published in prestigious journals such as Scientific Reports, Nano Energy and Psychopharmacology.

In The Last Decade

Nianping Zhang

26 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianping Zhang China 12 117 86 46 45 40 26 326
Hasan Yousefi‐Manesh Iran 16 130 1.1× 71 0.8× 64 1.4× 37 0.8× 41 1.0× 29 464
Smaranda Ioana Mitran Romania 6 118 1.0× 79 0.9× 85 1.8× 43 1.0× 51 1.3× 20 396
Naijil George India 12 107 0.9× 100 1.2× 43 0.9× 78 1.7× 19 0.5× 15 429
Mohit Kumar India 17 258 2.2× 103 1.2× 44 1.0× 50 1.1× 59 1.5× 34 645
Sanchari Basu Mallik India 15 163 1.4× 63 0.7× 81 1.8× 43 1.0× 94 2.4× 20 512
Xia Xu China 9 131 1.1× 59 0.7× 28 0.6× 26 0.6× 40 1.0× 19 391
Sumit Barua South Korea 8 132 1.1× 103 1.2× 57 1.2× 66 1.5× 33 0.8× 13 385
Amani Alghamdi Saudi Arabia 13 183 1.6× 135 1.6× 37 0.8× 78 1.7× 21 0.5× 41 523
Hao Hong China 13 139 1.2× 106 1.2× 71 1.5× 59 1.3× 62 1.6× 23 495
Engy A. Abdel‐Rahman Egypt 11 159 1.4× 101 1.2× 54 1.2× 50 1.1× 38 0.9× 19 449

Countries citing papers authored by Nianping Zhang

Since Specialization
Citations

This map shows the geographic impact of Nianping Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianping Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianping Zhang more than expected).

Fields of papers citing papers by Nianping Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianping Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianping Zhang. The network helps show where Nianping Zhang may publish in the future.

Co-authorship network of co-authors of Nianping Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Nianping Zhang. A scholar is included among the top collaborators of Nianping Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianping Zhang. Nianping Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yanfei, et al.. (2025). Highly polarized piezoelectret embedded versatile haptic devices for immersive human-robot interactions. Nano Energy. 136. 110775–110775. 2 indexed citations
2.
Zhang, Nianping, et al.. (2024). Pharmacological mechanisms of puerarin in the treatment of Parkinson's disease: An overview. Biomedicine & Pharmacotherapy. 177. 117101–117101. 12 indexed citations
3.
Li, Yanjun, et al.. (2024). Rho kinase inhibitor Y-27632 downregulates IL-1β expression in mice with experimental autoimmune myocarditis. Scientific Reports. 14(1). 9763–9763. 5 indexed citations
4.
Zhang, Nianping, et al.. (2024). Investigation on Common Chronic Non-Communicable Diseases and Epidemiological Characteristics of Forsaken Elders Over 60 Years Old in Rural Areas of Datong, China. Risk Management and Healthcare Policy. Volume 17. 213–224. 2 indexed citations
5.
Zhang, Nianping, Xin Hua, Shuai Shao, et al.. (2023). Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review). Experimental and Therapeutic Medicine. 27(1). 23–23. 8 indexed citations
6.
Zhang, Nianping, et al.. (2023). A Modified Differentiation Protocol In Vitro to Generate Dopaminergic Neurons from Pluripotent Stem Cells. Journal of Biomaterials and Tissue Engineering. 13(10). 1017–1025. 1 indexed citations
7.
Zhao, Lu, Hui Xu, Nianping Zhang, et al.. (2023). Fabricating Aptamer-functionalized Ti3C2 therapeutic nanoplatform for targeted chemo-photothermal therapy of cancer. Materials & Design. 226. 111656–111656. 17 indexed citations
8.
Liu, Chengjiang, et al.. (2022). Effect of self-management of stroke patients on rehabilitation based on patient-reported outcome. Frontiers in Neuroscience. 16. 929646–929646. 6 indexed citations
9.
10.
Yan, Hailong, Yuqing Yan, Ye Gao, et al.. (2022). Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer’s disease. Scientific Reports. 12(1). 6625–6625. 14 indexed citations
11.
Yu, Xiao‐Jing, Tong Xiao, Xiaojing Liu, et al.. (2021). Effects of Nrf1 in Hypothalamic Paraventricular Nucleus on Regulating the Blood Pressure During Hypertension. Frontiers in Neuroscience. 15. 805070–805070. 8 indexed citations
12.
Gao, Xudong, et al.. (2021). The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High‐Income Countries: Canada, Korea, and Italy. BioMed Research International. 2021(1). 8829122–8829122. 7 indexed citations
13.
Yan, Yuqing, Ye Gao, Nianping Zhang, et al.. (2021). Inhibition of Rho Kinase by Fasudil Ameliorates Cognition Impairment in APP/PS1 Transgenic Mice via Modulation of Gut Microbiota and Metabolites. Frontiers in Aging Neuroscience. 13. 755164–755164. 27 indexed citations
14.
16.
Gao, Ye, Yuqing Yan, Nianping Zhang, et al.. (2019). The Rho kinase inhibitor fasudil attenuates Aβ1–42-induced apoptosis via the ASK1/JNK signal pathway in primary cultures of hippocampal neurons. Metabolic Brain Disease. 34(6). 1787–1801. 37 indexed citations
17.
Shi, Jing, Jianchun Pan, Jie Chen, et al.. (2018). Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice. Psychopharmacology. 235(8). 2377–2385. 2 indexed citations
18.
Xu, Liping, Chun Shi, Nianping Zhang, et al.. (2018). Effect of leukocyte inhibitory factor on neuron differentiation from human induced pluripotent stem cell-derived neural precursor cells. International Journal of Molecular Medicine. 41(4). 2037–2049. 12 indexed citations
19.
Zhang, Nianping, et al.. (2017). miR-146b-5p promotes the neural conversion of pluripotent stem cells by targeting Smad4. International Journal of Molecular Medicine. 40(3). 814–824. 6 indexed citations
20.
Chen, Jianliang, Dan Lin, Chong Zhang, et al.. (2014). Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems. Metabolic Brain Disease. 30(1). 129–136. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026